About 3Xper Innoventure Limited
Data last updated: 22 February 2026
3Xper Innoventure Limited is a public limited company based in Chennai City Corporation, Tamil Nadu, India. It specialises in pharma contract r and d, a part of the broader pharmaceuticals sector. Incorporated on 12 May 2023.
Registered with ROC Chennai under CIN U21001TN2023PLC160370.
Capital: an authorised share capital of ₹300 Cr and a paid-up capital of ₹300 Cr. It is led by directors including Govindarajan Narayanan and Annamalai Meyyappan.
Last AGM: 21 July 2025. Financial statements filed for year ended 31 March 2025. Office: Chennai City Corporation, Tamil Nadu.
The company has a workforce of approximately 55 employees as per the latest available data.
The company is associated with 1 brand - 3Xper Innoventure. As per MCA filings, the company has open charges of ₹75 Cr on record.
For more details, the company can be reached via its website 3xper.com.
-
EmailLocked
-
TelephoneLocked
-
WebsiteLocked
-
Social Media
-
Registered AddressChola Crest C54 – 55 & Super B – 4, Thiru – Vi – Ka Industrial Estate Guindy, Chennai City Corporation, Tamil Nadu, India – 600032
-
IndustryPharma, Pharma Contract R&D
- Historical Financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Litigation, compliance and MCA filings
- PDF report delivered after checkout
Associated Brands with 3Xper Innoventure Limited
3Xper Innoventure Limited operates one associated brand: 3xper Innoventure. These brands represent 3Xper Innoventure Limited's diversified market presence and brand portfolio.
| Brand | Description | Website |
|---|---|---|
| Offers contract research, development, and manufacturing for pharma and biotech companies. | 3xper.com |
Competitors & Alternatives of 3Xper Innoventure Limited
Brands and companies operating in the same space as 3Xper Innoventure Limited include Pharmaron, Pfizer, Lonza and 6 more.
| Competitor | Description | Location | Founded |
|---|---|---|---|
Pharmaron
|
Drug discovery and development services for small molecules are provided. | Beijing, China, China | 2003 |
Pfizer
|
Pharmaceutical products for treating multiple diseases are provided. | New York, United States, United States | 1849 |
Lonza
|
CDMO services for pharma, biotech, and specialty ingredients are provided. | Basel, Switzerland, Switzerland | 1897 |
Boehringer Ingelheim
|
Generic drugs and clinical research services are provided globally. | - | 1885 |
LabConnect
|
Laboratory testing, clinical trial research, and biopharma services are provided. | Johnson City, United States, United States | 2002 |
Beta Drugs
|
Developer of therapeutics for oncology and dermatology | Panchkula, India, India | 2005 |
Evergreen Theragnostics
|
Radiopharmaceutical manufacturing and regulatory services are provided. | Jersey City, United States, United States | 2019 |
Ainos
|
Novel point-of-care testing and low-dose interferon therapeutics are developed. | San Diego, United States, United States | 1986 |
Biomatter
|
Provider of synthetic biology and AI-based technology for generative protein design | Vilnius, Lithuania, Lithuania | 2018 |
Board of Directors of 3Xper Innoventure Limited
3Xper Innoventure Limited is currently managed by 5 directors, with 7 former directors having served the organization. The current Directors play a crucial role in shaping the company's strategic direction and governance.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Govindarajan Narayanan | Whole-Time Director | 12 May 2023 | 3 Years 2 Months | Current |
|
Annamalai Meyyappan
Also directs:
3Xper Innoventure Labs Limited, Ti Medical Private Limited, Moshine Electronics Private Limited and 3 more
|
Individual Subscriber | 12 May 2023 | 3 Years 2 Months | Current |
|
Mukesh Ahuja
Also directs:
Tube Investments Of India Limited, Ti Clean Mobility Private Limited, Shanthi Gears Limited and 5 more
|
Director | 12 May 2023 | 3 Years 2 Months | Current |
| Srinivasan Krithika | Individual Subscriber | 12 May 2023 | 3 Years 2 Months | Current |
|
Vellayan Subbiah
Also directs:
Srf Limited, Tube Investments Of India Limited, Cholamandalam Financial Holdings Limited and 5 more
|
Director | 12 May 2023 | 3 Years 2 Months | Current |
Financials of 3Xper Innoventure Limited FY 2025 filings available
Ten-year financial statements for 3Xper Innoventure Limited
Historical statement values and trend charts require an active report plan.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Charges & Borrowings of 3Xper Innoventure Limited
| Date | Lender | Amount | Status |
|---|---|---|---|
| 02 Jul 2024 | The Hongkong and Shanghai Banking Corporation Limited | ₹75 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at 3Xper Innoventure Limited
View historical data on people associated with 3Xper Innoventure Limited, including employment history and EPFO contributions.
Employee and EPFO history for 3Xper Innoventure Limited
Monthly headcount, contribution history, establishment records, and filing compliance require an active report plan.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
GST Compliance of 3Xper Innoventure Limited
GST registrations and filing compliance for 3Xper Innoventure Limited
State-wise registrations, return filing status, HSN and SAC details, and jurisdiction records require an active report plan.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
Credit Ratings, Litigation & Regulatory Alerts for 3Xper Innoventure Limited
Credit ratings, litigation, and regulatory alerts for 3Xper Innoventure Limited
Agency ratings, court records, regulatory events, and entity-specific compliance alerts require an active report plan.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by 3Xper Innoventure Limited
MSME payment history for 3Xper Innoventure Limited
Amounts outstanding to micro and small suppliers, delay reasons, and MSME-1 filing history require an active report plan.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of 3Xper Innoventure Limited
Corporate group structure for 3Xper Innoventure Limited
Parent, subsidiary, associate, joint venture, and ownership records require an active report plan.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
MCA Filings & Documents of 3Xper Innoventure Limited
MCA filings and documents for 3Xper Innoventure Limited
Official forms, annual returns, financial statements, charge filings, and document dates require an active report plan.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Recent Activity on 3Xper Innoventure Limited
Frequently Asked Questions about 3Xper Innoventure Limited
3Xper Innoventure Limited is an active public limited company in the pharma sector based in Chennai City Corporation, Tamil Nadu, India. It was incorporated on 12 May 2023 (3+ years old) and is registered under CIN U21001TN2023PLC160370. The company has 55 employees.
The current directors of 3Xper Innoventure Limited are:
- Govindarajan Narayanan - Whole-Time Director
- Annamalai Meyyappan - Individual Subscriber
- Mukesh Ahuja - Director
- Srinivasan Krithika - Individual Subscriber
- Vellayan Subbiah - Director
The primary industry of 3Xper Innoventure Limited is pharma. The company specifically operates in pharma contract r and d. The company is currently active in this sector.
3Xper Innoventure Limited can be reached at the registered office: Chola Crest C54 – 55 & Super B – 4, Thiru – Vi – Ka Industrial Estate Guindy, Chennai City Corporation, Tamil Nadu, India – 600032, or through the website 3xper.com.
The authorised capital is ₹300 Cr, and the paid-up capital is ₹300 Cr.
The company has its registered office at Chola Crest C54 – 55 & Super B – 4, Thiru – Vi – Ka Industrial Estate Guindy, Chennai City Corporation, Tamil Nadu, India – 600032.